SOURCES SOUGHT
66 -- Mass Spectrometer
- Notice Date
- 8/4/2008
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-08-1045218
- Point of Contact
- Karen R. Petty,, Phone: 301-827-8774
- E-Mail Address
-
karen.petty@fda.hhs.gov
- Small Business Set-Aside
- Total Small Business
- Description
- Solicitation: FDA-08-1045218 Agency/Office: Food and Drug Administration Location: Office of Acquisitions and Grants Services Title: Mass Spectrometer Description(s): THIS IS A SOURCES SOUGHT NOTICE to determine the availability and capability of small businesses (including certified 8(a), Small Disadvantaged, and HUBZone firms; veteran and service-disabled veteran-owned small businesses, and women-owned small businesses. This notice is for planning purposes only, and does not constitute an Invitation for Bids, a Request for Proposals, Solicitation, Request for Quotes, or an indication the Government will contract for the items contained herein. This notice is not to be construed as a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. The Government does not reimburse respondents for any cost associated with submission of the information being requested or reimburse expenses incurred to interested parties for responses to this sources sought. Any responses received will not be used as a proposal. The U.S. Food and Drug Administration (FDA) is seeking to identify any sources with capabilities of providing a Mass Spectrometer in accordance with the following specifications. Specifications: General Specifications-The instrument must be capable of obtaining full scan mass spectra, as well as tandem mass spectra (known as MS/MS spectra) in the product ion, parent ion and constant neutral loss mode. It must also have the capability to perform true reaction monitoring, in which the instrument can be set up to admit a precursor ion, fragment it, and sequentially monitor selected product ions as the mass spectrometer is stepped from one product ion to the next (see specifications below). The instrument must have multiple sources, including but not limited to an ESI and APCI source. Programmable drying gas temperature: The mass spectrometer must utilize temperature programmable drying gas temperature which can be manipulated throughout a chromatographic run. I am interested in degrade with increased temperature and others need higher drying gas temperatures to be efficiently ionized, a system which incorporates temperature programmable drying gas is essential. Single tune file: In order to be the most robust and simple analyzer possible, the instrument must use one tune file for both the optics and analyzer. Multiple tune files make for complex analysis conditions for the operator. A single tune file will allow me to be more efficient with my time. Instrument footprint: In order to maximize bench space the mass spectrometer must utilize an 180o collision cell and must have dimensions of not more than 15 in/38 cm (h) x 19.5 in/50 cm (w) x 28 inch/71 cm (d). Bench space is critical in the lab, and any extra space made available will contribute to the productivity of the lab Ion sources: The mass spectrometer must also come equipped with both an Atmospheric Pressure Chemical Ionization (APCI) interface as well as an Electrospray Ionization (ESI) interface. As not all compounds are responsive to ESI, an APCI interface is absolutely necessary for our types of analyses. Lenseless design: The mass spectrometer must utilize a lensless design for the analyzer. The curved collision cell and lensless analyzer design increase sensitivity by reducing chemical noise in the mass spectrometer and increasing ion transmission. Both of the features increase the overall sensitivity of the instrument. Flexibility: To have the most flexible system available, the mass spectrometer must be able to be converted by the lab personnel from an LC/MS/MS to a GC/MS/MS with an optional interface kit. Companies are encouraged to respond if they have the capability and capacity to provide the identified services with little or no disruption of services to the current users at the FDA. Interested small business potential offerors are encouraged to respond to this notice. However, be advised that generic capability statements are not sufficient for effective evaluation of respondents' capacity and capability to perform the specific work as required. Responses must directly demonstrate the company's capability, experience, and/or ability to marshal resources to effectively and efficiently perform each of the tasks described above at a sufficient level of detail to allow definitive numerical evaluation; and evidence that the contractor can satisfy the minimum requirements listed above wile in compliance with FAR 52.219-14 ("Limitations on Subcontracting"). Failure to definitively address each of these factors will result in a finding that respondent lacks capability to perform the work. Responses to this notice shall be limited to 15 pages, and must include: 1. Company name, mailing address, e-mail address, telephone and fax numbers, website address (if available), and the name, telephone number, and e-mail address of a point of contact having the authority and knowledge to clarify responses with Government representatives. 2. Name, title, telephone number, and e-mail addresses of individuals who can verify the demonstrated capabilities identified in the responses. 3. Business size for NAICS 611310 with size limitation standards of $6.5M and status, if qualified as an 8(a) firm (must be certified by the Small Business Administration (SBA), Small Disadvantaged Business (must be certified by SBA), Woman-Owned Small Business, HUBZone firm (must be certified by SBA), and/or Service-Disabled Veteran Owned Small Business (must be listed in the VetBiz Vendor Information Pages). 4. DUNS number, CAGE Code, Tax Identification Number (TIN), and company structure (Corporation, LLC, partnership, joint venture, etc). Companies also must be registered in the Central Contractor Registration (CCR) at www.ccr.gov to be considered as potential sources. 5. Identification of the firm's GSA Schedule contract(s) by Schedule number and contract number and SINs that are applicable to this potential requirement are also requested. 6. If the company has a Government approved accounting system, please identify the agency that approved the system. Please submit copies of any documentation, such as letters or certificates to indicate the firm's status (see item #3 above). To the maximum extent possible, please submit non-proprietary information. Any proprietary information submitted should be identified as such and will be properly protected from disclosure. Interested offerors should submit their capability statement not exceeding fifteen (15) pages in length, excluding standard brochures. SUBMISSIONS ARE DUE no later than 3:00pm, Eastern Time, August 11, 2008. The capabilities response shall be e-mailed to: Karen.petty@fda.hhs.gov. All information received in response to this notice that is marked Proprietary will be handled accordingly. Responses to the notice will not be returned, nor will there be any ensuing discussions or debriefings of any responses. Information provided in response to this notice will be used to assess alternatives available for determining how to proceed in the acquisition process. This notice is part of Government Market Research, a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for or award a competitive contract. The FDA will use the information submitted in response to this notice at its discretion and will not provide comments to any submission; however, the content of any responses to this notice may be reflected in subsequent solicitation. FDA reserves the right to contact any respondent to this notice for the sole purpose of enhancing FDA's understanding of the notice submission. This announcement is Government market research, and may result in revisions in both its requirements and its acquisition strategy based on industry responses. It is emphasized that this is a notice for planning and information purposes only and is not be construed as a commitment by the government to enter into a contractual agreement, nor will the government pay for information solicited.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=c24cc29d843d1bbb20cc4dec13362113&tab=core&_cview=1)
- Record
- SN01630726-W 20080806/080804223415-c24cc29d843d1bbb20cc4dec13362113 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |